The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.

ADCC, antibody-dependent cellular cytotoxicity CDC, complement-dependent cytotoxicity CHO, Chinese hamster ovary CLEC-2, C-type lectin-like receptor 2 Dog podoplanin Monoclonal antibody Mouse-canine chimeric antibody PBS, phosphate-buffered saline PDPN, podoplanin SCC, squamous cell carcinomas dPDPN dPDPN, dog podoplanin mAb, monoclonal antibody

Journal

Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 24 10 2018
accepted: 14 11 2018
entrez: 7 12 2018
pubmed: 7 12 2018
medline: 7 12 2018
Statut: epublish

Résumé

Podoplanin (PDPN) is a type I transmembrane heavily glycosylated sialoglycoprotein that is expressed in normal tissues such as pulmonary type I alveolar cells, renal podocytes, and lymphatic endothelial cells. PDPN overexpression in cancerous tissue is associated with hematogenous metastasis through interactions with the C-type lectin-like receptor 2 (CLEC-2). Previously, we have reported the development of a mouse monoclonal antibody (mAb), PMab-38 (IgG

Identifiants

pubmed: 30519645
doi: 10.1016/j.bbrep.2018.11.005
pii: S2405-5808(18)30257-7
pmc: PMC6260363
doi:

Types de publication

Journal Article

Langues

eng

Pagination

23-26

Commentaires et corrections

Type : ErratumIn

Références

Monoclon Antib Immunodiagn Immunother. 2018 Jun;37(3):162-165
pubmed: 29608407
Monoclon Antib Immunodiagn Immunother. 2017 Apr;36(2):72-76
pubmed: 28387591
Acta Neuropathol. 2006 May;111(5):483-8
pubmed: 16596424
Pathol Int. 2005 Feb;55(2):83-6
pubmed: 15693854
Oral Oncol. 2018 Mar;78:126-136
pubmed: 29496040
Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):63-66
pubmed: 29256716
Monoclon Antib Immunodiagn Immunother. 2016 Dec;35(6):293-299
pubmed: 27801621
Oncotarget. 2015 Nov 3;6(34):36003-18
pubmed: 26416352
J Immunol. 2013 Jun 15;190(12):6239-49
pubmed: 23690472
Vet Immunol Immunopathol. 2014 Jan 15;157(1-2):31-41
pubmed: 24268690
Monoclon Antib Immunodiagn Immunother. 2016 Aug;35(4):212-6
pubmed: 27380308
J Biol Chem. 1995 Jul 28;270(30):17815-22
pubmed: 7629082
Monoclon Antib Immunodiagn Immunother. 2016 Oct;35(5):263-266
pubmed: 27788030
Oncogene. 2004 Nov 4;23(52):8552-6
pubmed: 15361850
Vet Immunol Immunopathol. 2015 Apr 15;164(3-4):148-59
pubmed: 25764941
Monoclon Antib Immunodiagn Immunother. 2016 Dec;35(6):304-306
pubmed: 27918691
Monoclon Antib Immunodiagn Immunother. 2018 Nov;37(5):218-223
pubmed: 30362926
Sci Rep. 2014 Aug 01;4:5924
pubmed: 25080943
Protein Expr Purif. 2014 Mar;95:240-7
pubmed: 24480187
Tumour Biol. 2005 Jul-Aug;26(4):195-200
pubmed: 16006773
Am J Pathol. 1997 Oct;151(4):1141-52
pubmed: 9327748
Monoclon Antib Immunodiagn Immunother. 2017 Dec;36(6):291-295
pubmed: 29161183
Monoclon Antib Immunodiagn Immunother. 2017 Apr;36(2):68-71
pubmed: 28339303

Auteurs

Yukinari Kato (Y)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
New Industry Creation Hatchery Center, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Tomokazu Ohishi (T)

Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, 18-24 Miyamoto, Numazu-shi, Shizuoka 410-0301, Japan.

Manabu Kawada (M)

Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, 18-24 Miyamoto, Numazu-shi, Shizuoka 410-0301, Japan.

Naoya Maekawa (N)

Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo 060-0818, Japan.

Satoru Konnai (S)

Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo 060-0818, Japan.
Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo 060-0818, Japan.

Shunsuke Itai (S)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Shinji Yamada (S)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Mika K Kaneko (MK)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Classifications MeSH